INTRODUCTION {#S1}
============

The six-member telomere shelterin complex is vital for eukaryotic cells. It functions to regulate telomere elongation by telomerase, as well as to protect the ends of linear chromosomes from degradation and recognition as DNA damage sites ([@R3]; [@R16]; [@R27]). In human cells, the shelterin complex consists of double-stranded DNA (dsDNA) binders TRF1 and TRF2, single-stranded DNA (ssDNA) binder POT1, as well as RAP1, TIN2, and TPP1 ([@R8]). The shelterin connects telomeric dsDNA with ssDNA by forming a proteinaceous bridge via protein interactions within the shelterin. Specifically, telomeric dsDNA binders TRF1 and TRF2 recruit TIN2 and RAP1 to the telomere; TIN2 then recruits TPP1-POT1 complex to the telomere ([@R39]). Since POT1 directly binds to the telomeric ssDNA, where telomere elongation by telomerase happens, TRF1-initiated POT1 loading to the telomere 3′ end via shelterin interactions is believed to directly block telomerase from elongating telomeres ([@R23]). Shelterin architecture in fission yeast, *Schizosaccharomyces pombe*, closely resembles that of mammals ([@R25]) ([Figure 1A](#F1){ref-type="fig"}). Either its dsDNA binder Taz1 (homolog of hTRF1/2) ([@R7]) or its ssDNA binder Pot1 ([@R5]) can independently recruit other shelterin components, Rap1, Poz1 (hTIN2 homolog), and Ccq1, to telomeres ([@R25]). Using *S. pombe* as a model system, we recently discovered that the complete linkage within the shelterin complex, rather than individual shelterin components per se, regulates the extendibility of telomeres by telomerase ([@R17]). Disruption of this linkage leads to unregulated telomere elongation. These previous studies emphasized a critical role of shelterin complex assembly in telomere length regulation. Indeed, several human POT1 variants were found to predispose to the development of familial melanoma and carriers of some of these mutations have elongated telomeres ([@R31]; [@R34]). These mutations may allow cancer cells to achieve replicative immortality, and thus provide the same outcome as previously identified TERT (telomerase reverse transcriptase) promoter mutations ([@R12]; [@R15]) that lead to cancer-specific TERT activation ([@R6]). Most of melanoma-associated POT1 mutations reside in the highly conserved oligonucleotide and oligosaccharide-binding (OB) domains of POT1, thereby disrupting POT1-telomeric ssDNA interaction ([@R31]; [@R34]). In addition, one mutation, Ala532Pro (A532P), was found in the C terminus of POT1, which contains the TPP1-binding domain ([@R34]). However, the mechanism by which POT1-A532P facilitates melanoma formation is still unknown. To understand the role of shelterin complex in regulating telomere states, we need to have accurate information about protein-protein interfaces between shelterin components, and therefore a complete dissection of the individual interactions. However, obtaining structural information regarding this complex by X-ray crystallography or nuclear magnetic resonance (NMR) has proved challenging. Alternative approaches are needed to enable us to acquire protein interfaces information without the requirement for high-resolution structures.

In recent years, crosslinking mass spectrometry (XL-MS) has become an increasingly valuable tool for studying protein-protein interactions and structural interrogation of protein complexes due to technological advancement in mass spectrometry (MS) instrumentation, new development of crosslinking reagents and bioinformatics tools to facilitate MS analysis of crosslinked peptides ([@R9]; [@R18]; [@R19], [@R20]; [@R29]; [@R41]; [@R46]), and an innovative algorithm developed for integrative structural biology utilizing distance restraints obtained from inter-subunit chemical crosslinking ([@R40]). XL-MS studies involve protein crosslinking through a chemical linker simultaneously reacting with two amino acids that are in proximity to each other. Digestion of the crosslinked protein complex followed by peptide sequencing leads to the identification of crosslinked peptides, and consequently, proximal residue pairs. Because these crosslinked residues are constrained by the length of the linker used, the distribution of the crosslinked residue pairs helps probe protein-protein proximity. Unlike X-ray crystallography or NMR, XL-MS does not require samples with high concentration and purity. It also captures interactions from dynamic states, thus making it applicable to a broad range of protein complexes. However, XL-MS has proved challenging due to the complex fragmentation pattern of crosslinked peptides, which frequently prevents unambiguous identification of the crosslinked sequences. Recently, a new class of MS-cleavable crosslinker, disuccinimidyl sulfoxide (DSSO) was developed, which contains two symmetric MS-cleavable sites that preferentially cleave prior to the breakage of peptide backbones during collision-induced dissociation (CID) ([@R19]). In combination with multistage mass spectrometry (MS^n^) and tailored bioinformatics tools, DSSO-based XL-MS workflow enables easy interpretation and unambiguous identification of crosslinked peptides and has proved effective in elucidating structures of protein complexes ([@R19], [@R20]).

In this study, we have developed a strategy *MICro-MS* (Mapping Interfaces via Crosslinking-Mass Spectrometry) by combining DSSO-based XL-MS workflow, phylogenetic sequence analysis, and in vitro binding assays to identify protein-interaction interfaces without the need of obtaining high-resolution 3D structure of the complex. With this strategy, we comprehensively probed protein-protein proximity in Tpz1-centered complex in fission yeast shelterin and identified separation-of-function mutants of Ccq1, Poz1, or Pot1 that selectively disrupt their respective interactions with Tpz1. The identified mutants further reveal the critical regulatory roles of Tpz1 in telomere maintenance. We also found that POT1-A532P, a melanoma-associated POT1 mutation ([@R34]), lies in the POT1-TPP1 interface and causes weakened TPP1-POT1 interaction. Just as disrupting POT1-telomeric ssDNA interaction in other POT1 mutants predisposed to melanoma, such as Y89C, Q94E, R273L, and S270N ([@R31]; [@R34]), defective TPP1-POT1 interaction by hPOT1-A532P mutation equivalently breaks the complete shelterin linkage between telomeric dsDNA and ssDNA. Therefore, our work links shelterin connectivity to tumorigenesis. In addition, our *MICro-MS* strategy of identifying separation-of-function mutants to dissect protein complexes for functional examinations will be generally applicable to other important multi-component protein complexes in the cell.

RESULTS {#S2}
=======

Identifying Contact Residues in Protein-Protein Interaction Interfaces by *MICro-MS* {#S3}
------------------------------------------------------------------------------------

We set out to utilize chemical crosslinking coupled with mass spectrometry (XL-MS) to identify contact residues located in the interfaces of interacting telomere shelterin components. Since mutations of the contact residues can selectively disrupt defined interactions within shelterin components, this strategy will allow us to identify separation-of-function mutants of shelterin components. Separation-of-function mutants can selectively block specific interactions without disrupting overall protein complex architecture. Thus, they should poise us to elucidate the roles of specific shelterin interactions in telomere maintenance without perturbing their roles in chromosome end protection.

The general workflow is depicted in [Figure 1B](#F1){ref-type="fig"}, in which DSSO crosslinking of purified protein complexes was first carried out to covalently connect residues within certain three-dimensional distance in the protein pairs that are specifically reactive to the crosslinker. Although the crosslinked residues in the protein complex might not be directly involved in mediating protein-protein interactions, they should at least be close to each other surrounding the interface. Therefore, the locations of the crosslinked residues point out where the binding interface is likely to be. The optimal crosslinking conditions were used to yield sufficient amounts of crosslinked products as evaluated by SDS-PAGE. The resulting crosslinked protein complexes were digested either in-solution or in-gel with trypsin and/or chymotrypsin to obtain the maximum coverage of detectable crosslinked peptides for LC-MS^n^ analysis. The mass to charge ratios of DSSO-crosslinked peptides were first measured during MS^1^ analysis, and they were then subjected to collision induced dissociation (CID) during MS^2^. Due to the presence of the robust sulfoxide C-S cleavage sites in the linker region, MS^2^ analysis of a DSSO inter-linked peptide would lead to physical separation of the two crosslinked peptide constituents, thus allowing for MS^3^ sequencing of single peptide chains and subsequent identification using conventional database searching tools ([@R19]). Integration of the MS^n^ data (i.e., MS^1^, MS^2^, and MS^3^) results in simplified and unambiguous identification of DSSO-crosslinked peptides ([@R19]).

After identifying the crosslinked peptides and localizing lysine residues conjugated by DSSO, we mapped these residues to the phylogenetically compiled sequence alignment. We reasoned that functionally important residues (such as those for enzymatic activity, structural-fold determination, and protein complex assembly) should be evolutionarily conserved, and therefore represent leading candidates that contribute to protein-protein interactions. We introduced mutations to the conserved residues, especially the hydrophobic residues among them (as they constitute the hydrophobic core of protein-protein interactions), within approximately 8 to 15 amino acids from the crosslinked lysines, particularly in the regions where multiple lysine residues were identified as crosslinking points. In vitro GST pull-down and in vivo co-immunoprecipitation assays were subsequently performed to evaluate the degree that the introduced mutations can disrupt the targeted protein-protein interaction. Mutations of the contact residues in the protein-protein interaction interface should efficiently disrupt the protein interaction. We termed this integrated strategy to identify separation-of-function mutants disrupting specific protein interaction interfaces MICro-MS---Mapping Interfaces via Crosslinking-Mass Spectrometry.

Benchmarking *MICro-MS* with 3D Structure of Proteasome Subunits Rpn8-Rpn11 Complex {#S4}
-----------------------------------------------------------------------------------

Next, we assessed the applicability of MICro-MS to a protein complex with determined high-resolution 3D structure. In 2012, DSSO-based XL-MS strategy was employed to unravel the structural topology of *Saccharomyces cerevisiae* 19S proteasome regulatory particle ([@R20]). Five inter-subunit, DSSO-mediated crosslinks were identified between Rpn8 and Rpn11 subunits, suggesting their spatial proximity as well as potential direct protein interaction interfaces between Rpn8 and Rpn11. In 2014, two groups independently solved the crystal structure of heterodimer of the MPN (Mpr1--Pad1--N-terminal) domains of Rpn8 (1--179) and Rpn11 (2--239) ([@R28]; [@R45]). These two subunits primarily interact with each other through α helices forming two distinct interfaces. Interestingly, two pairs of DSSO-crosslinked lysines, Rpn8-K7:Rpn11-K218 and Rpn8-K28:Rpn11-K96, appear to be close to interface A and interface B, respectively, as shown in [Figures 2A--2C](#F2){ref-type="fig"}. The rest three identified lysine-crosslinks locate in the residues beyond the MPN domains and thus are not covered in the crystal structure. From the 3D structure, we calculated distances between the crosslinked lysine pairs to be 19.4 and 18.3Å, respectively, falling in the range of DSSO effective reaction distance (\~20 Å). In *Interface A* (shown in [Figure 2B](#F2){ref-type="fig"}), the hydrophobic core of the interface is formed by four-helix bundle between α1, α4 of Rpn8 and α1, α4 of Rpn11. Specifically, side chains from residues L15, L16, and L19 in α1 of Rpn8 and residues M212, L216 and L213 in α4 of Rpn11 are the essential constituents of the hydrophobic interface. Remarkably, these interface residues are adjacent (within 15 amino acids) in primary sequence to the crosslinked lysines---K7 in Rpn8 and K218 in Rpn11, respectively. Moreover, they belong to the most phylogenetically conserved residues around the crosslinking sites ([Figures S1A and S1B](#SD2){ref-type="supplementary-material"}). *Interface B* (shown in [Figure 2C](#F2){ref-type="fig"}) is located between α2 of Rpn8 and α2 of Rpn11. A cluster of four methio-nines: M76 and M79 from Rpn8 as well as M91 and M94 from Rpn11 build the core of the interface, which is flanked by salt bridges between Rpn8-R24 and Rpn11-T98 and between Rpn8-D20 and Rpn11-R100. Identified DSSO-crosslinked lysine pair Rpn8-K28:Rpn11-K96 lies at the edge of the interface, very close to the interface residues in primary sequence. Evidently, our benchmarking results demonstrate a strong correlation between DSSO-crosslinked lysine pairs and contact residues in protein-interaction interfaces in the primary sequence. Thus, we are set out to utilize MICro-MS to identify contact residues in interaction interfaces of protein complexes with no existing high-resolution 3D structure.

Dissecting the Ccq1-Tpz1 Interacting Interface via MICro-MS {#S5}
-----------------------------------------------------------

Tpz1, the fission yeast homolog of the mammalian shelterin component TPP1 ([@R14]; [@R22]; [@R33]; [@R42]; [@R47]), is a linchpin molecule interacting with three other shelterin components---Ccq1, Poz1 via its C-terminal domain (Tpz1-CTD), and with Pot1 using its N-terminal domain (Tpz1-NTD) ([Figure 1A](#F1){ref-type="fig"}) ([@R25]). Our previous work identified Tpz1 mutants that selectively disrupt the ability of Tpz1 to interact with each of its interacting partners and revealed an interesting interplay among the positive and negative regulators of telomere length homeostasis ([@R17]). To achieve a complete dissection of the protein-protein interactions between Tpz1 and its interacting shelterin components, and therefore to define the boundary between positive and negative telomere regulators, we decided to further map the Tpz1-interacting surfaces on Ccq1, Poz1, and Pot1, respectively.

Ccq1 is more than 700 amino acids long, and it is extremely labor intensive and tedious to identify its point mutations that disrupt Ccq1-Tpz1 interaction via mutating every phylogenetically conserved residue in Ccq1. We set out to gather interface information by utilizing MICro-MS strategy. As Ccq1 (130--439) interacts with Tpz1 (415--458), we co-expressed recombinant Ccq1 (130--439) with Tpz1 (415--458) in *E. coli* and purified the complex. We then subjected the complex to chemical crosslinking using an optimized concentration of DSSO---5.0 mM. As shown in [Figure 3A](#F3){ref-type="fig"}, the crosslinked Ccq1 (130--439) and Tpz1 (415--458) complex was observed, while the free form of both Ccq1 (130--439) and Tpz1 (415--458) decreased concomitantly. The covalently crosslinked Ccq1 (130--439)/Tpz1 (415--458) shows molecular weight of \~72 kDa. This agrees with the Ccq1-Tpz1 complex forming a dimer of Ccq1-Tpz1 heterodimer, as we observed in gel filtration analysis, in which the protein complex was examined in its native form ([Figure S2A](#SD2){ref-type="supplementary-material"}). The tryptic digests of crosslinked Ccq1-Tpz1 complexes were then analyzed by LC-MS^n^. [Figure 3B](#F3){ref-type="fig"} illustrates a representative MS^n^ analysis for unambiguous identification of DSSO crosslinked peptides. As shown, MS^2^ analysis of a selected peptide (m/z 554.0333^4+^) yielded two peptide fragment pairs, i.e., α~A~/β~T~ (m/z 420.75^2+^/678.31^2+^) and α~T~/β~A~ (m/z 432.20^2+^/662.83^2+^), which is characteristic to a hetero-inter-linked peptide (α-β) ([@R19]). Each fragment (α~A,~ β~T,~ α~T~, or β~A~) represents one of the two crosslinked peptide constituents modified with the defined remnants of the linker after its cleavage, thus suggesting this peptide is a DSSO inter-linked peptide. The dominant fragment pair ions (α~A~/β~T~) were subsequently subjected to MS^3^ analysis, in which the series of b (b~2~\~b~5~) and y (y~1~\~y~5~) ions detected for the α~A~ fragment unambiguously identified it as ^171^IQEK~A~IR^176^ of Ccq1, while the series of b (b~2~\~b~7~, b~9~) and y (y~2~\~y~3~, y~5~, y~7~\~y~9~) ions detected for β~T~ unambiguously identified the peptide as ^434^K~T~PIPDYDFM(Ox)K^443^ of Tpz1. Finally, integration of the MS^n^ data precisely identifies the inter-link between Tpz1-K434 and Ccq1-K174, suggesting their close proximity in three-dimensional space. Based on our previous study, Tpz1-L449A is able to disrupt Ccq1-Tpz1 interaction both in vitro and in fission yeast cells. The MS^n^ identification of Tpz1-K434 and Ccq1-K174 crosslinked by DSSO in the Tpz1-Ccq1 complex ([Figure 3B](#F3){ref-type="fig"}) is remarkable, because Tpz1-K434 is only 15 amino acids away from the previously confirmed Ccq1-interacting site on Tpz1 (L449) ([@R17]). We therefore suspected that Ccq1 residues that mediate Ccq1-Tpz1 interaction should also be around K174 of Ccq1, the residue crosslinked to Tpz1-K434. Next, we introduced point mutations individually to several conserved residues around the K174 region of Ccq1 ([Figure S2B](#SD2){ref-type="supplementary-material"}), and then the purified recombinant Ccq1 mutants produced in *E. coli* were subjected to GST pull-down assays to evaluate their binding ability to GST-Tpz1-CTD. As shown in [Figure 3C](#F3){ref-type="fig"}, among nine Ccq1 mutants, Ccq1-L151R and Ccq1-F157A/K174E completely abolished association between Ccq1 and Tpz1. In addition, Ccq1-L171R, Ccq1-K174E, Ccq1-I175R, and Ccq1-F178R all significantly diminished Ccq1-Tpz1 interaction, whereas Ccq1-V152R and Ccq1-L177R still retain wild-type binding to Tpz1. Furthermore, we also confirmed that Ccq1 mutations, which interfere with Ccq1-Tpz1 interaction in vitro, also affect full-length Ccq1-Tpz1 interaction to the similar degree in co-immunoprecipitation assays ([Figure 3D](#F3){ref-type="fig"}); however, they still maintain their interactions with Clr3---the interaction partner of Ccq1 in the SHREC complex ([@R36]) ([Figure S2C](#SD2){ref-type="supplementary-material"}). In addition, chromatin immunoprecipitation (ChIP) analysis of these Ccq1 mutants indicates that they can localize to telomeres as well ([Figure S2D](#SD2){ref-type="supplementary-material"}). Therefore, we identified separation-of-function mutants of Ccq1, specifically disrupting Ccq1-Tpz1 interaction.

After obtaining Ccq1 mutants disrupting Ccq1-Tpz1 interaction, we further asked whether these Ccq1 mutants eliminate the function of Ccq1 as a positive regulator of telomere length. As predicted, telomere length in *ccq1-L151R* and *ccq1-F157A/K174E pombe* cells, in which Ccq1-Tpz1 interaction is completely abolished, is stable but \~150 bp shorter than that in the wild-type cells, reminiscent of *tpz1-L449A* cells ([Figures S2E and 3E](#SD2){ref-type="supplementary-material"}) ([@R2]; [@R17]). *S. pombe* cells bearing *ccq1^+^* mutations that significantly diminish Ccq1-Tpz1 interaction, such as *ccq1-L171R*, *ccq1-I175R*, and *ccq1-F178R*, also have similarly shorter telomeres as *tpz1-L449A* cells. However, cells bearing *ccq1^+^* mutations, *ccq1-V152R* and *ccq-L177R*, which have little effect on Ccq1-Tpz1 interaction, maintain wild-type telomere length. Furthermore, *tpz1-L449A/ccq1-F157A/K174E* double-mutant cells have an almost identical telomere phenotype as either *ccq1-F157A/K174E* or *tpz1-L449A* cells ([Figure S2F](#SD2){ref-type="supplementary-material"}), indicating the mutations, either in Tpz1 or in Ccq1, affect the same functionality in telomere maintenance pathway. Much like *tpz1-L449A* cells, which maintain their short telomeres via homologous recombination pathway involving *rad51^+^*, *ccq1-F157A/K174E* cells also require *rad51^+^* to maintain their telomeres as deletion of *rad51^+^* in *ccq1-F157A/K174E* immediately abrogates the stably maintained short telomeres in *ccq1-F157A/K174E* cells ([Figure S2G](#SD2){ref-type="supplementary-material"}). Taken together, utilizing MICro-MS, we were able to identify Ccq1 mutants that are defective in interacting with Tpz1, and we found that these Ccq1 mutants are functionally equivalent to *tpz1-L449A* in telomere maintenance.

A Poz1 Mutation that Prevents Tpz1 Binding Results in Dramatic Telomere Elongation {#S6}
----------------------------------------------------------------------------------

Having successfully employed MICro-MS to dissect Ccq1-Tpz1 interaction, we next applied this approach to define the significance of the Poz1-Tpz1 interaction. Using the same procedure as described above for Ccq1-Tpz1 complex, we analyzed DSSO-crosslinked Poz1-Tpz1 complex ([Figure 4A](#F4){ref-type="fig"}) to identify crosslinked peptides and the lysine pairs that make the linkages. Interestingly, Tpz1-K499, a residue adjacent to Tpz1-I501---a previously identified Poz1-interacting residue in Tpz1 ([@R17]), was found to crosslink to K180, K190, and K192 of Poz1 ([Figures 4B](#F4){ref-type="fig"}, [S3A, and S3B](#SD2){ref-type="supplementary-material"}). In addition, Tpz1-K500 was also observed to crosslink to Poz1-K190 ([Figure S3C](#SD2){ref-type="supplementary-material"}). This result suggests that a region around K180 and K192 of Poz1 may contain Tpz1 contact sites ([Figure S3D](#SD2){ref-type="supplementary-material"}). We therefore introduced mutations individually to three conserved residues around this region, Poz1-W174R, R196E, and W209A, and performed GST pull-down assay to evaluate their Tpz1 binding ability. Among these three Poz1 mutants, only Poz1-R196E completely abrogated Poz1-Tpz1 interaction as shown in [Figure 4C](#F4){ref-type="fig"}. Accordingly, we found that Poz1-R196E also caused loss of Poz1-Tpz1 interaction in the *S. pombe* cells as detected by co-immunoprecipitation assays ([Figure 4D](#F4){ref-type="fig"}).

We generated a yeast strain carrying the *poz1-R196E* mutation to evaluate its importance for telomere length homeostasis. *poz1-R196E* mutant cells had dramatically elongated telomeres ([Figures 4E](#F4){ref-type="fig"} and [S3E](#SD2){ref-type="supplementary-material"}), consistent with the phenotype previously observed for *tpz1-I501R* mutant strain ([@R17]), which also fails to form the Poz1-Tpz1 complex. Moreover, when *poz1-R196E* was coupled with *tpz1-I501R*, the double mutant also showed elongated telomere, similar to *poz1-R196E* single mutant with no additional telomere elongation ([Figure 4F](#F4){ref-type="fig"}). These results indicate that Poz1-R196 is indeed functionally equivalent to Tpz1-I501 in mediating Tpz1-Poz1 interaction, a key linkage point in the negative regulation force imposed by shelterin complex upon telomerase.

Pot1 Is a Negative Regulator of Telomere Length and Protects Telomeres Redundantly with Tpz1 {#S7}
--------------------------------------------------------------------------------------------

In *S. pombe*, Pot1 is the direct single-stranded telomeric DNA binder and is responsible for telomere 3′ end protection by forming a complex with Tpz1 ([@R25]). Deletion of either protein can result in chromosome circularization, whereas disruption of Tpz1-Pot1 interaction by the Tpz1-I200R mutation conversely leads to telomere elongation ([@R17]). Pot1 interacts with the N-terminal domain of Tpz1 (Tpz1-NTD), which is distinct from Ccq1 and Poz1 binding regions in the C-terminal domain of Tpz1 (Tpz1-CTD). To achieve the complete dissection of the interfaces in Tpz1-mediated negative regulation of telomere elongation, we aimed to identify regions in Pot1 that mediate its interaction with Tpz1-NTD. As shown in [Figure 5A](#F5){ref-type="fig"}, efficient crosslinking by DSSO was achieved with the purified Pot1--Tpz1-NTD complex. Further MS^n^ analyses revealed that two lysine residues (K180 and K226) in proximity to I200 position of Tpz1 were crosslinked to Pot1 (K403, K535, and K553) ([Figures 5B](#F5){ref-type="fig"} and [S4A--S4C](#SD2){ref-type="supplementary-material"}). To design separation-of-function mutations in Pot1 for specific disruption of the Pot1-Tpz1 interaction, several conserved residues around the crosslinked lysines were mutated ([Figure S4D](#SD2){ref-type="supplementary-material"}), and the mutants were tested for their interactions with Tpz1 both in vitro (by GST pull-down) ([Figure 5C](#F5){ref-type="fig"}) and in vivo (by co-immunoprecipitation) ([Figure 5D](#F5){ref-type="fig"}). We found that Pot1-I453R and Pot1-F520A completely disrupt Pot1-Tpz1 binding both in vitro and in vivo. In addition, we examined the crystal structure of the *Oxytricha nova* homolog of Pot1-Tpz1 complex---TEBP-α/β ([@R13]) and found that secondary structure prediction of Pot1 imposed onto its homologous TEBP-α/β structure placed I453 and F520 of Pot1 at the protein interaction interface ([Figure S4D](#SD2){ref-type="supplementary-material"}), consistent with our binding data. We performed ChIP analyses to evaluate telomeric localizations of Pot1 and Ccq1 in Pot1-Tpz1 interaction-defective Pot1 mutant strains ([Figures S4E and S4F](#SD2){ref-type="supplementary-material"}), demonstrating that these mutations only disrupt Pot1-Tpz1 interaction with minimum effect on Pot1 or Ccq1 telomere association. In agreement with this, we found that these Pot1 mutants can bind to telomeric ssDNA in gel-shift assays ([Figure S4G](#SD2){ref-type="supplementary-material"}). Reminiscent of *tpz1-I200R* cells, telomeres in both *pot1-I453R* and *pot1-F520A* mutant cells are elongated ([Figures 5E](#F5){ref-type="fig"} and [S4H](#SD2){ref-type="supplementary-material"}) ([@R17]), indicating that Pot1 is also a negative regulator of telomere length. However, when we coupled *pot1-I453R* or *pot1-F520A* with *tpz1-I200R*, the double mutant showed no telomere signal, with part of the subtelomeric regions disappeared concomitantly ([Figures 5F](#F5){ref-type="fig"} and [S4I](#SD2){ref-type="supplementary-material"}). These results strongly suggest that there is an alternative pathway that Tpz1 is involved in, in addition to the Pot1 pathway, to redundantly protect telomere erosion.

In summary, we have successfully employed MICro-MS to comprehensively map Tpz1-centered protein-protein interfaces in fission yeast shelterin. As a result, we successfully identified mutants of Ccq1, Poz1, and Pot1 that selectively disrupt their respective interactions with Tpz1, the linchpin molecule that is functionally positioned between the positive and negative regulators of telomere elongation.

A Human POT1 Variant in Family Melanoma Patients Has Compromised hPOT1-hTPP1 Interaction {#S8}
----------------------------------------------------------------------------------------

Replicative telomere attrition is one of the key restriction mechanisms that form a key barrier to infinite cell proliferation. As a result, a hallmark of cancer cells is their ability to circumvent multiple regulatory mechanisms that normally restrict cell proliferation ([@R11]). The integrity of telomere shelterin structure is essential for telomere length homeostasis, which, in turn, enables the anti-proliferative barrier set by short telomeres ([@R10]). Indeed, it has been shown that long telomeres can bypass the requirement of telomerase activation in the process of tumorigenesis ([@R37]). Recently, two studies have linked 4%--6% of familial melanoma cases to germline variants in the gene encoding human POT1, the first shelterin component found to be mutated in cancer ([@R31]; [@R34]). Among these hPOT1 variants, many alter key residues in the N-terminal OB domains of POT1, causing the inability of hPOT1 to bind to telomeric ssDNA and leading to longer telomeres ([@R31]; [@R34]). However, one familial melanoma hPOT1 variant (hPOT1-A532P) contains a point mutation in the C terminus of hPOT1, and therefore is unlikely to disrupt POT1-ssDNA binding. Given our knowledge gained from fission yeast Pot1-I453R, which disrupts Pot1-Tpz1 interaction and aligns to where hPot1-A532 locates ([Figure S5](#SD2){ref-type="supplementary-material"}), we suspected that the hPOT1-A532P mutation might reside in the TPP1 (human counterpart of fission yeast Tpz1) interaction surface. Thus, hPOT1-A532P might disrupt hPOT1-hTPP1 interaction, thereby facilitating tumorigenesis by causing inappropriate telomere elongation, similar to fission yeast Pot1-I453R. To test this possibility, we in vitro translated hPOT1 and its mutants and evaluated their binding abilities to GST-hTPP1-NTD. Notably, hPOT1-A532P, as well as two other mutants in the adjacent regions, hPOT1-V529R and L538R, has significantly weakened hPOT1-hTPP1 interaction ([Figures 6A and 6B](#F6){ref-type="fig"}). This result emphasizes the importance of the intact "shelterin bridge" in telomere length regulation and explains how mutations in a shelterin component overcome the replicative telomere barrier, and thus lead to tumorigenesis.

DISCUSSION {#S9}
==========

MICro-MS Is Effective in Identifying Functional Protein-Protein Contact Residues {#S10}
--------------------------------------------------------------------------------

Identifying interfaces between protein components, and generating separation-of-function mutants thereafter, is a prerequisite for elucidating the functional role of each component in the large multi-protein complex, such as the shelterin complex at the end of our chromosomes. For proteins that have multiple interaction partners, such as Tpz1 in fission yeast shelterin complex, its separation-of-function mutants are absolutely required to elucidate the specific roles of each of these protein interactions. However, X-ray crystallography and NMR spectroscopy have been the main experimental techniques that provide the structural details of protein-protein interfaces, and consequently, the knowledge to design separation-of-function mutants. Both approaches are very time consuming, labor intensive, and extremely demanding on the chemical and biophysical behavior of the protein complex. Thus, only a limited number of protein complexes are suitable for these high-resolution techniques. Here, utilizing XL-MS with a recently developed MS-cleavable linker DSSO, coupled with phylogenetic and biochemical analyses, we present an integrated strategy ([Figure 1B](#F1){ref-type="fig"}) that successfully identified contact residues in Tpz1-centered protein-protein interfaces of fission yeast shelterin. The DSSO-based XL-MS workflow greatly facilitates the identification of crosslinked peptides, which, in turn, provides essential information about regions that are very likely to mediate protein-protein interactions. Phylogenetic analysis further narrows down the candidate residues to be mutated in the regions close to crosslinked residues, and, thereafter, GST pull-down assays identify residues directly involved in and contribute to the protein-protein interaction. This strategy can be directly applied to other protein complexes due to its simplicity, sensitivity, efficiency, accuracy, and speed. In addition, recent studies suggested the existence of evolutionarily co-varied residues as good candidates for contact residues across protein interaction interface because compensatory mutations occur in the interfaces to maintain interaction stability during evolution ([@R24]; [@R26]; [@R44]). Therefore, evolutionary covariation analysis can be combined with MICro-MS to more accurately identify interface residues by prioritizing candidate residues to mutate.

For MICro-MS, chemical crosslinking sets up the foundation for the overall outcome of this strategy. The linker length of the chemical crosslinker is crucial for linking residues pairs around the protein-interaction interface. DSSO has a linker length of 10.1 Å, resulting in potential linkages between lysines within \~20Å. This is a distance that has been determined to be optimal for specifically crosslinking lysines across interfaces. When lysines are scarce in one of the interacting proteins or both, other crosslinking reagents targeting other amino acid residues such as cysteines or acidic residues ([@R21]) can be utilized similarly to determine protein interaction contacts. Interfaces that are small can be potentially probed by crosslinkers with shorter linker length such as EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride), which targets acidic residues (D and E), with zero linker length. Incorporating CID-inducible cleavage group into chemical crosslinkers with different linker lengths and/or reactive groups targeting various side chains apparently has urgent need.

For structurally heterogeneous samples, crosslinking mass spectrometry has the advantage of probing proximal regions of interacting proteins in different conformations. Unlike most other biophysical techniques, in which sample heterogeneity interferes with the generation of characteristic signals, for MICro-MS, different protein interactions existing in different conformations can be identified as distinct crosslinking pairs with crosslinked peptide counts proportional to its population in the sample. Moreover, capturing stable interactions in general is much easier than identifying transient ones, but stability is not a requirement; this is another aspect of MICro-MS that allows the stabilization of transient complexes through chemical crosslinking for subsequent analysis to identify residues close to the interfaces. Finally, methods such as yeast two-hybrid and peptide arrays are known to identify binary interactions and have been used extensively to identify domains that mediate protein interaction. They can also be utilized to identifying protein-protein interacting surfaces residues when coupled with alanine scanning of the whole or selected region of the protein pairs. In addition, once protein domains responsible for interaction are identified via yeast two hybrid, they can be subject to MICro-MS, which provides leading candidate residues for both methods to test, significantly reducing the number of residues to mutate. It is worth mentioning that MICro-MS allows the study of each individual interface in multi-protein complexes concurrently.

Shelterin Connectivity, Telomere Length Regulation, and Familial Melanoma {#S11}
-------------------------------------------------------------------------

Our recent study of fission yeast shelterin revealed that the complete linkage within shelterin, connecting double-stranded and single-stranded telomeric DNA, governs the telomerase-nonextendible state of the telomere ([@R17]). In this study, taking advantage of XL-MS with a MS-cleavable linker strategy, we achieved complete dissection of Tpz1-centered shelterin component interactions (Tpz1-Ccq1, Tpz1-Poz1, Tpz1-Pot1) and obtained separation-of-function mutants that facilitate the investigation of their roles in telomerase regulation, telomere protection, and potentially other cellular functions such as telomere silencing ([@R38]) and meiosis. These mutants emphasize the importance of shelterin connectivity in negatively regulating telomerase as we concluded from Tpz1 separation-of-function mutants. This is because any mutation that disrupts the shelterin connectivity from dsDNA to ssDNA, no matter in Tpz1 or in the Tpz1 interacting partners, uniformly leads to over-elongated telomeres. They also make exploring the regulation of telomere length homeostasis by shelterin components, especially its activator Ccq1 ([@R43]), possible.

In addition, our study also has clinical significance. Since fission yeast and human have homologous shelterin components and architecture, the shelterin interaction interface information obtained from fission yeast can be easily applied to the human shelterin. This information will not only help design separation-of-function mutants of human shelterin components, it will also offer mechanistic insights to a constellation of genetic diseases caused by impaired telomere maintenance due to defects in telomere shelterin. Human POT1 is the first member of shelterin components whose loss-of-function variants were found to predispose to human cancers, such as familial melanoma ([@R31]; [@R34]) and chronic lymphocytic ([@R30]; [@R35]). Many identified POT1 mutations occurs in the N-terminal OB-fold domain that directly binds to the telomeric ssDNA. All four well-studied OB-fold domain mutants of hPOT1 identified in familial melanoma patients, e.g., POT1-Y89C, POT1-Q94E, POT1-R273L, and POT1-S270N, fail to bind to telomeric ssDNA and cause cells to have elongated telomeres ([@R31]; [@R34]). This can be mechanistically explained by the loss of complete linkage connecting telomeric dsDNA to ssDNA via shelterin, due to the inability of the mutants to bind to ssDNA, and thereby keeping the telomere constitutively in the extendible state. With sufficiently long telomeres reserve, tumorigenesis will not be impeded by the lack of telomerase in the cell, and cancer cells thus can automatically overcome the anti-proliferative barrier set by short telomeres ([@R37]). Long telomeres help cells gain replicative time in order to accumulate other mutations (loss of function for tumor suppressor and gain of function for tumor activator). Exploiting homology between fission yeast and human shelterins, we find that another POT1 mutation (POT1-A532P), found in familial melanoma patients, affects POT1-TPP1 interaction. Based on what we learned from fission yeast, disrupting any point in the proteinaceous shelterin bridge between telomeric dsDNA and ssDNA would lead to elon-gated telomeres. Therefore, in that sense, defect in POT1-TPP1 interaction is equivalent to that in POT1-ssDNA interaction, both acting to downregulate the negative force of telomere elongation. Recently, in addition to POT1, point mutations clustered in the POT1-interacting domain of TPP1 were found in melanoma patients ([@R1]), presumably disrupting POT1-TPP1 interaction just as POT1-A532P does. Interestingly, gain-of-function mutations in the hTERT promoter, which increase gene expression of hTERT, were recently found to be driver alterations in melanoma and other cancers ([@R12]; [@R15]). Upregulation of positive regulators of telomere elongation (such as hTERT) is equivalent to downregulation of the negative regulators (such as the shelterin bridge) (as shown in [Figure 7](#F7){ref-type="fig"}) in leading to the deregulated telomere over-elongation, both helping the cancer cells to achieve replicative immortality, during and after the transformation.

EXPERIMENTAL PROCEDURES {#S12}
=======================

Yeast Strains, Gene Tagging, and Mutagenesis {#S13}
--------------------------------------------

Fission yeast strains used in this study are listed in [Table S1](#SD3){ref-type="supplementary-material"}. Single mutant strains were constructed by one-step gene replacement of the entire open reading frame (ORF) with the selectable marker. Double- and triple-mutant strains were produced by mating, sporulation, dissection, and selection followed by PCR verification of genotypes. Genes were fused to specific epitope tags at the C terminus by homologous recombination; the pFA6a plasmid modules were used as templates for PCR ([@R4]; [@R32]). Point mutations were made by site-directed mutagenesis PCR using the high-fidelity polymerase *Pfu* (Agilent). All mutations were confirmed by DNA sequencing (Eton).

Protein Expression and Purification {#S14}
-----------------------------------

Plasmids for recombinant protein expression in *E. coli* were transformed into Rosetta-BL21 (DE3) cells. Protein expression was induced with 0.4 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) for 4 hr at 30°C or 0.2 mM IPTG overnight at 16°C. Cells were disrupted by sonication in lysis buffer (25 mM Tris-HCl \[pH 8.0\], 350 mM NaCl, 15 mM imidazole, 5 mM β-mercaptoethanol, 1 mM PMSF, 2 mM benzamidine). The supernatant was incubated with Ni-NTA (QIAGEN) resin for 1 hr. After washing, the bound protein was eluted from the beads with elution buffer containing 300 mM imidazole. Some proteins were further purified with additional ion-exchange and/or gel filtration steps.

GST Pull-Down Assay {#S15}
-------------------

15 μg GST fusion protein in 30 μl GST pull-down buffer (50 mM Tris-HCl \[pH 8.0\], 200 mM NaCl, 10 mM b-ME, 0.1% Tween 20) was incubated with 20 μl glutathione Sepharose resin (QIAGEN) for 1 hr. Then the target protein (20 μg in 120 μl GST pull-down buffer) was added to the resin. After 1-hr incubation with rotation, the resin was washed three times, and the protein was eluted with 15 μl 2 × SDS loading buffer at 95°C for 5 min. The eluted proteins were resolved by 10% SDS-PAGE and visualized by Coomassie blue staining.

Crosslinking Mass Spectrometry Analysis {#S16}
---------------------------------------

45 μl purified protein complex (4.5 mg/ml for Tpz1-Ccq1; 4 mg/ml for Tpz1-Poz1; 1.25 mg/ml for Tpz1-Pot1) was mixed with 5 μl DSSO (dissolved in DMSO) to the final concentration as indicated in results. Crosslinking was performed for 30 min and quenched with 2 μl 1 M Tris-HCl (pH 8.0) for 15 min. The cysteine residues were reduced with 4 mM TCEP and alkylated with 20 mM iodoacetamide in dark, followed by terminating alkylation reaction with 20 mM cysteine for 30 min. The crosslinked proteins were digested overnight at 37°C with trypsin (2%, w/w) and chymotrypsin (5%, w/w), separately. Crosslinked peptides were analyzed by LC MS^n^ utilizing an LTQ-Orbitrap XL MS (Thermo Fisher Scientific) coupled online with an Easy-nLC 1000 (Thermo Fisher Scientific) as described ([@R19]). Each MS^n^ experiment consists of one MS scan in FT mode (350--1,400 m/z, resolution of 60,000 at m/z 400) followed by two data-dependent MS^2^ scans in FT mode (resolution of 7,500) with normalized collision energy at 20% on the top two MS peaks with charges 3^+^ or up, and three MS^3^ scans in the LTQ with normalized collision energy at 35% on the top three peaks from each MS^2^.

Identification of DSSO Crosslinked Peptides by LC-MS^n^ {#S17}
-------------------------------------------------------

MS3 data were subjected to a developmental version of Protein Prospector (v.5.10.10) for database searching, using Batch-Tag with mass tolerances for parent ions and fragment ions set as ±20 ppm and 0.6 Da, respectively. Trypsin was set as the enzyme with five maximum missed cleavages allowed. A maximum of five variable modifications were also allowed, including protein N-terminal acetylation, methionine oxidation, N-terminal conversion of glutamine to pyroglutamic acid, asparagine deamidation, and cysteine carbamidomethylation. In addition, three defined modifications on uncleaved lysines and free protein N termini were also selected: alkene (A: C~3~H~2~O, +54 Da); sulfenic acid (S: C~3~H~4~O~2~S, +104 Da), and unsaturated thiol (T: C~3~H~2~OS, +86 Da) modifications, due to remnant moieties of DSSO. Initial acceptance criteria for peptide identification required a reported expectation value ≤0.1.

Integration of MS^n^ data was carried out using the in-house program Link-Hunter, a revised version of the previously written Link-Finder program, to validate and summarize crosslinked peptides as previously described ([@R19], [@R20]).

Co-immunoprecipitation {#S18}
----------------------

The indicated strains were grown in YEAU and harvested at OD~600~ = 0.6--0.8. Then the cell pellets were cryogenically disrupted with FastPrep MP with two pulses (60 s) of bead-beating in ice-cold lysis buffer (50 mM HEPES \[pH 7.5\], 140 mM NaCl, 15 mM EGTA, 15 mM MgCl~2~, 0.1% NP40, 0.5 mM Na~3~VO~4~, 1 mM NaF, 2 mM PMSF, 2 mM benzamidine, Complete proteinase inhibitor \[Roche\]). The crude extracts were clarified by centrifuge for 10 min and adjusted to 15 mg/ml. Anti-Flag M2 affinity gel (Sigma) or anti-Myc resin (9E10, Santa Cruz Biotechnology) was equilibrated with same lysis buffer, and immunoprecipitation was performed for 3 hr at 4°C. Then, the proteins were eluted with 30 μl 0.1 M glycine (pH 2.0) at room temperature for 10 min with gentle shaking and neutralized by Tris-HCl (pH 8.0) immediately after elution. Eluted proteins were resolved by 8% SDS-PAGE and then subjected to western blotting. Western blot analysis was performed using monoclonal anti-Flag (M2-F1804, from Sigma), monoclonal anti-Myc (9E10, from Covance), monoclonal anti-HA (F-7, from Santa Cruz), anti-Ccq1 rabbit serum, and anti-Cdc2 (y100.4, from Abcam). 20 μg whole-cell extract was used for input control.

Telomere Length Analysis {#S19}
------------------------

*S. pombe* cells grown in 5 ml YEAU overnight were harvest for genomic DNA extraction. EcoRI-digested genomic DNA was separated on 1% agarose gel and then transferred to N^+^ membrane (GE Healthcare) via capillary blot. The telomeric probe was prepared as previously described ([@R17]). The template of *pol1^+^* was amplified with 5′ primer (GGTGCAGAAGACGGTCTGCAAG) and 3′ primer (CTTAGCATGCAGAAGCATGCGC), and the *pol1^+^* probe was generated by High Prime (Roche). Southern blots were imaged using a Bio-Rad phosphorimager.

In Vitro Translation Coupled with GST Pull-Down Assay {#S20}
-----------------------------------------------------

hPOT1 in a pET28 vector was mutated by site-directed mutagenesis PCR. WT and all mutants were in vitro expressed using TnT coupled reticulocyte lysate kit (Promega) following the manual. Briefly, a 25-μl reaction containing 20 μl rabbit reticulocyte lysate, 0.5 μg plasmid, 1 μl 1mM methionine, and 1 μl \[^35^S\]methionine was incubated at 30°C for 90 min. 22 μl of each in vitro translation reaction was directly applied to GST pull-down assay as previously described, but with 7 μg of GST fusion protein. The pull-downs were resolved by 8% SDS-PAGE and imaged with a Bio-Rad phosphorimager.

Electrophoretic Mobility Shift Assay {#S21}
------------------------------------

20 nM 5′ end ^32^P-labeled ssDNA (GTTACGGTTACAGGTTACG) was mixed with Pot1 proteins of specified concentrations in 20 μl reaction buffer (20 mM Tris-HCl \[pH 8.0\], 100 mM NaCl, 5 mM DTT, 2 mM MgCl~2~, 10% glycerol). The mixtures were then incubated at 4°C for 30 min. The protein-ssDNA complex were resolved by 7% non-denaturing polyacrylamide gel and imaged with a Bio-Rad phosphorimager.

Chromatin Immunoprecipitation {#S22}
-----------------------------

Fresh *S. pombe* cells in liquid culture were fixed with an 11% formaldehyde solution (11% formaldehyde, 100 mM NaCl, 1 mM EDTA \[pH 8.0\], 0.5 mM EGTA, 50 mM Tris-HCl \[pH 8.0\]) for 20 min, followed by termination with 125 mM glycine for 5 min. Cell pellets were disrupted in 400 μl of lysis buffer (50 mM HEPES \[pH 7.5\], 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, complete proteinase inhibitor \[Roche\], 1 mM PMSF, 1 mM benzamidine, 1 mM Na~3~VO~4~, 1 mM NaF) with FastPrep MP. After three pulses (1 min) of beads-beating, at least 90% cells were broken. Cell extracts were sonicated three times for 30 s in 18 cycles using a Bioruptor. Clarified cell extracts were incubated with anti-Myc resin (9E10, Santa Cruz) or anti-Ccq1 rabbit serum followed by protein G-agarose (Roche) for 3 hr at 4°C. Then, the beads were washed twice with lysis buffer, lysis buffer with 500 mM NaCl, wash buffer, and 1 × 3 TE buffer sequentially. Each sample was added with 100 μl of 10% Chelex100 resin and boiled for 15 min, followed by 20 μg proteinase K treatment for 30 min at 55°C. The recovered DNA were denatured with 0.4 M NaOH and transferred to a Hybond-XL membrane by using a slot module. The blots were hybridized with telomeric probe; the same blot was then re-probed with rDNA probe after stripping.
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###### Highlights

-   MICro-MS can identify contact residues in protein interaction interfaces

-   MICro-MS allows dissection of Tpz1-centered shelterin interfaces in fission yeast

-   A POT1 variant in melanoma weakens shelterin interaction between POT1 and TPP1

![Fission Yeast Shelterin Complex and a Strategy---*MICro-MS*---to Dissect Its Interaction Interfaces\
(A) Fission yeast shelterin complex is composed of telomeric sequence-specific double-stranded and single-stranded DNA binding proteins, Taz1 and Pot1, respectively, accompanied by their protein interaction partners, Rap1, Poz1, and Tpz1, forming a bridge between Taz1 and Pot1. If the deletion of a telomere protein causes telomere elongation, this protein is regarded as a negative regulator of telomere lengthening, and is therefore labeled "−", otherwise, labeled "+". For clarity, the stoichiometry of each individual component is not indicated in the figure and therefore only one copy of each component is shown.\
(B) Schematic illustration of MICro-MS strategy to identify contact residues at the interfaces of protein interactions. The MS-cleavable crosslinker DSSO chemically crosslinks neighboring lysine (K) residue pairs of two interacting proteins, which, in turn, can be identified via sequencing protease-digested crosslinked peptide pairs by multistage tandem mass spectrometry. The identified crosslinked residues are then mapped to the phylogenetically compiled sequence alignment. Around the locations of the crosslinked residues, mutations are individually introduced to the conserved residues. In vitro GST pull-down and/or in vivo co-immunoprecipitation assays are subsequently performed to evaluate the degree that introduced mutations disrupt the targeted protein-protein interaction.](nihms-717290-f0002){#F1}

![Benchmarking MICro-MS Using Rpn8-Rpn11 Complex\
(A) Crystal structure of Rpn8-Rpn11 heterodimer is presented with Rpn8 colored in blue and Rpn11 colored in green. The two interfaces are designated as Interface A and Interface B. The crosslinked lysines boxed in orange are connected with orange dashed lines; the distances between the lysine pairs are shown next to the lines.\
(B) Close-up view showing a DSSO-crosslinked lysine pair (Rpn8-K7:Rpn11-K218) and interface A nearby in Rpn8-Rpn11 complex. The hydrophobic core of the interface is formed by four-helix bundle between α1, α4 of Rpn8 and α1, α4 of Rpn11. Specifically, side chains from residues L15, L16, and L19 (labeled in blue) in α1 of Rpn8 and residues M212, L216, and L213 (labeled in green) in α4 of Rpn11 are the essential constituents of the hydrophobic interface.\
(C) Close-up view showing a DSSO-crosslinked lysine pair (Rpn8-K28:Rpn11-K96) and interface B nearby in Rpn8-Rpn11 complex. Interface B is located between α2 of Rpn8 and α2 of Rpn11. A cluster of four methionines: M76 and M79 from Rpn8 (labeled in blue) as well as M91 and M94 from Rpn11 build the core of the interface (labeled in green), which is flanked by salt bridges between Rpn8-R24 and Rpn11-T98 and between Rpn8-D20 and Rpn11-R100.\
Identified DSSO-crosslinked lysine pair Rpn8-K28:Rpn11-K96 (linked by an orange dash line) lies at the edge of the interface, very close to the interface residues in primary sequence.](nihms-717290-f0003){#F2}

![Dissecting Ccq1-Tpz1 Interacting Interface via MICro-MS\
(A) SDS-PAGE of Ccq1 (130--439) and Tpz1 (415--458) complex before and after being crosslinked by DSSO.\
(B) (a) MS^2^ spectrum of a quadruply charged crosslinked peptide α-β (m/z 554.2863^4+^), in which two characteristic peptide fragment pairs were detected: α~A~/β~T~ (m/z 420.75^2+^/678.31^2+^) and α~T~/β~A~ (m/z 432.20^2+^/662.83^2+^). MS^3^ spectra of (b) α~A~ (m/z 420.75^2+^) and (c) β~T~ (m/z 678.31^2+^) fragment ions detected in (a), which unambiguously identified their sequences as IQEK~A~IR of Ccq1 and K~T~ PIPDYDFM~Ox~K of Tpz1, respectively, demonstrating a linkage between residue K174 of Ccq1 and K434 of Tpz1. K~A~, alkene-modified lysine; K~T~, unsaturated thiol-modified lysine.\
(C) In vitro GST pull-down assays testing the binding of Ccq1 mutants and Poz1 to GST-Tpz1-CTD (406--508). GST-Tpz1-CTD-L449A serves as the negative control. Input: 1/20 of Ccq1 and 1/5 Poz1 before their incubation with GST-Tpz1-CTD.\
(D) Co-immunoprecipitation (coIP) assays evaluating the binding between full-length Tpz1 and Ccq1 mutants. *tpz1-L449A* serves as the negative control. Cdc2 was shown as the loading control. Input: 1/30 of input WCE (whole-cell extract).\
(E) Southern blot analysis of EcoRI-digested genomic DNA using the telomere DNA probe for the indicated *ccq1* mutant strains from successive re-streaks on agar plates. *ccq1* mutants disrupting Ccq1-Tpz1 interaction have shorter telomeres. In the telomere length analysis southern blots presented in this paper, the 1 kb plus marker from Life Technologies is used. Wild-type cells are denoted as "WT" in the blot. *pol1^+^* indicates the EcoRI-digested *pol1^+^* DNA fragment as loading control.](nihms-717290-f0004){#F3}

![A Poz1 Mutation that Prevents Tpz1 Binding Results in Dramatic Telomere Elongation\
(A) SDS-PAGE of full-length Poz1 and Tpz1 (406--508) complex before and after being crosslinked by DSSO.\
(B) (a) MS^2^ spectrum of a triply charged crosslinked peptide α-β (m/z 429.5608^3+^) in which two characteristic peptide fragment pairs were detected: α~A~/β~T~ (m/z 304.19^2+^/662.30^+^) and α~T~/β~A~ (m/z 320.17^2+^/630.33^+^). MS^3^ spectra of (b) α~A~ (m/z 304.19^2+^) and (c) β~T~ (m/z 662.30^+^) fragment ions detected in (a), which unambiguously identified their sequences as DWK~A~K of Tpz1 and HK~T~IR of Poz1, respectively, demonstrating a linkage between residue K192 of Poz1 and K499 of Tpz1. K~A~, alkene-modified lysine; K~T~, unsaturated thiol-modified lysine.\
(C) In vitro GST pull-down assays testing the binding of Poz1 mutants to GST-Tpz1-CTD (406--508). Poz1-R196E (colored in green) is defective in binding to GST-Tpz1-CTD. GST-Tpz1-CTD-I501R/R505E serves as the negative control. Input: 1/15 of the samples before their incubation with GST-Tpz1-CTD.\
(D) *poz1-R196E* disrupts Poz1-Tpz1 interaction as evaluated by coIP assays. *tpz1-I501R* serves as the negative control. Cdc2 was shown as the loading control. Input: 1/30 of input WCE.\
(E) Telomere length analysis southern blots for the indicated *poz1* mutant strains from successive re-streaks on agar plates. *poz1-R196E* causes telomere elongation.\
(F) Double-mutant strain *poz1-R196E/tpz1-I501R* cells have elongated telomeres similar to those of *poz1-R196E* or *tpz1-I501R* cells.](nihms-717290-f0005){#F4}

![Pot1 Is a Negative Regulator of Telomere Length and Protects Telomeres Redundantly with Tpz1\
(A) SDS-PAGE of full-length Pot1 and Tpz1-NTD (1--234) complex before and after being crosslinked by DSSO.\
(B) (a) MS^2^ spectrum of a quadruply charged crosslinked peptide α-β (m/z 983.5108^4+^) in which two characteristic peptide fragment pairs were detected: α~A~/β~T~ (m/z 749.89^2+^/1209.12^2+^) and α~T~/β~A~ (m/z 764.88^2+^/1193.13^2+^). MS3 spectra of (b) α~A~ (m/z 748.89^2+^) and (c) β~T~ (m/z 1209.12^2+^) fragment ions detected in (a), which unambiguously identified their sequences as DIK~A~ANNIQFHWK of Tpz1 and EYIPVIGNTK~T~TDHQSLTFLQK of Pot1, respectively, indicating a linkage between residue K180 of Tpz1 and K535 of Pot1. K~A~, alkene-modified lysine; K~T~, unsaturated thiol-modified lysine.\
(C) In vitro GST pull-down assays testing the binding of Pot1 mutants to GST-Tpz1-NTD (2--234). Pot1-I453R and Pot1-F520A (colored in orange) abolish the in vitro interaction with GST-Tpz1-NTD. GST-Tpz1-NTD-I200R serves as the negative control. Input: 1/15 of the samples before their incubation with GST-Tpz1-NTD.\
(D) CoIP assays evaluating the binding of Pot1 mutants and Ccq1 to full-length Tpz1. *pot1-I453R* and *pot1-F520A* completely disrupt Pot1-Tpz1 interaction. *tpz1-I200R* serves as the negative control. Cdc2 was shown as the loading control. Input: 1/30 of input WCE.\
(E) Telomere length analysis southern blots for the indicated *pot1* mutant strains from successive re-streaks on agar plates. *pot1-I453R* and *pot1-F520A* strains, in which Pot1-Tpz1 interaction is disrupted, have elongated telomeres.\
(F) Telomere deprotection phenotype was observed in both *pot1-F520A/tpz1-I200R* and *pot1-I453R/tpz1-I200R* double mutants.](nihms-717290-f0006){#F5}

![A Human Family Melanoma-Associated POT1 Variant Has Compromised hPOT1-hTPP1 Interaction\
(A) In vitro GST pull-down assays testing the binding of hPOT1 mutants to GST-hTPP1-NTD (89--334). hPOT1-A532P (boxed in red) was identified in familiar melanoma patients. hPOT1-V529R and hPOT1-L538R (boxed in red) also negatively affect the interaction between hPOT1 and GST-hTPP1-NTD. All hPOT1 (WT and mutants) are labeled with ^35^S and visualized by Bio-Rad Phosphorimager. GST-hTPP1-NTD and GST are visualized by Coomassie blue staining.\
(B) Quantification of the binding between GST-hTPP1-NTD and hPOT1 mutants from (A). The interaction between GST-hTPP1-NTD and hPOT1-WT is set to 1.](nihms-717290-f0007){#F6}

![Model of Telomere Length Dysregulation-Related Tumorigenesis\
Upregulation of positive regulators of telomere elongation (such as hTERT) is equivalent to downregulation of the negative regulators (such as the shelterin bridge) in leading to the deregulated telomere over-elongation, both helping the cancer cells to achieve replicative immortality, a key barrier to tumorigenesis.](nihms-717290-f0008){#F7}
